"should say so beforehand,"
In ideal world, likely big pharma stooge raises it after trial complete at review panel meetings though.
This is new tech they don't require much of an excuse!
Sr-GVHD, FDA should of put childrens lives ahead of ticking a box on potency but didn't!
They maybe dead but they didn't get ripped off!!
Even though 9-1 favourable vote!
Any submission will have to be squeaky clean not a wiff of conflict of interests, imo, my hope!
Ann: Mesoblast Update on Chronic Low Back Pain Program, page-258
-
- There are more pages in this discussion • 171 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
-0.030(2.03%) |
Mkt cap ! $1.655B | |||
| Open | High | Low | Value | Volume |
| $1.48 | $1.51 | $1.43 | $6.613M | 4.498M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2482 | $1.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.46 | 27045 | 2 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |